Becoming Better Predictors of Death Region 5 Collaborative Chuck Zollinger Administrative Director, Organ Recovery.

Slides:



Advertisements
Similar presentations
Clinical Competency Committees (CCC): 3 different perspectives Sharon Dabrow: Pediatrics PD Cuc Mai: Internal Medicine PD Todd Kumm: Radiology PD.
Advertisements

Let’s Start at the Beginning: It Starts with a Call Nancy Biagioni Director of Donor Development & Education.
Region 3 Monitors April What is a REED? It is a “process” whereby the IEP team reviews existing evaluation data to make evaluation decisions about.
Culture of Donation Doug Miller Symposium 2013 Gundersen Lutheran Medical Center LaCrosse, WI.
Quality Improvement/ Quality Assurance Amelia Broussard, PhD, RN, MPH Christopher Gibbs, JD, MPH.
How Do I Evaluate Workflow?
Independent Educational Evaluations Developed by Contra Costa SELPA As Recommended for LEA Board Policy
Tabletop Exercise Meningitis Outbreak
Donation Process: Preparing for the Gift Breakout Session A Presenters: Jennifer Do, RN, Unit Director, Surgical Transplant ICU, Ronald Reagan UCLA Medical.
Developing Classroom Assessments for the NGSS What evidence of student thinking is needed to determine if a student has met a PE (performance expectation)?
Donation After Cardiac Death May 26, 2010 Margie Whittaker, RN MSN.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Informed Consent and HIPAA Tim Noe Coordinating Center.
Understanding your child’s IEP.  The Individualized Education Plan (IEP) is intended to help students with disabilities interact with the same content.
Quality Assessment of Your Donor Program Clinton Coil, MD, Patient Safety Officer Laura Schneider, RN, BSN, Trauma Program Manager Susan Black, RNP, MSN,
Presented at The 129th Annual Meeting of the American Public Health Association Atlanta, GA, October 21–25, 2001 Presented by Amanda Honeycutt Abigail.
State of Maine: Quality Management and National Core Indicators.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Unit 10. Monitoring and evaluation
Organ Donation Past, Present and Future Donor Identification and Referral Jeremy Brown Huw Twamley 4 th June LONDON.
Arizona Early Intervention Program IDEA 2011 Requirements -Screening-
Acting on Every Donor’s Designated Decision: The Time is Now! Susan Stuart I Said Yes.
Ed Palmisano 06/2005 Evaluation Procedures An Introduction for New School Psychologists and Members of the M- Team.
UAGA Calif. Health & Safety CMS Collaborative Joint Commission 400.
Curriculum Focused Visit In Search of Standards. People’s minds are changed by observation and not through argument. (Will Rogers) What gets monitored.
Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.
OPTN OPTN/UNOS Ethics Committee Spring 2012 Regional Meeting Update Chair, Alexandra Glazier, MPH, JD Vice-Chair, Peter Reese, MD.
The Process of Accreditation
Honoring Donor Families Through Collaboration Sharon Elliott, BSN, RN, Nurse Supervisor Paula Marbach, RN, Charge Nurse Donor Council Breakout.
Arizona Early Intervention Program IDEA 2011 Requirements -Assessment -
Arizona Early Intervention Program -Assessment Part II-
Scientific Method. Ask a question Ask a question.
Copyright © 2007 Pearson Education Canada 7-1 Chapter 7: Audit Planning and Documentation.
Monitoring and Evaluation in MCH Programs and Projects MCH in Developing Countries Feb 24, 2009.
Ante mortem interventions in DCD Dr Malcolm Watters Regional Clinical Lead for Organ Donation 1.
Chapter 1.1 – What is Science?. State and explain the goals of science. Describe the steps used in the scientific method. Daily Objectives.
Peer Visits Tools for sharing best practices Becky Ames GOH In-House Coordinator, Champaign County.
Neurologically-Aware Donors: Donation After Circulatory Death Noël Stout, LPN, CTBS Myrna Garcia, BA Family Support Coordinators.
Think Like a Scientist! Mrs. Sabatier. THE SCIENTIFIC METHOD THE SCIENTIFIC METHOD The process, or steps scientists use to gather information and answer.
Donation After Cardiac Death Margie Whittaker RN, MSN, CCRN, CNRN April 12, 2010.
GEA TOOL KIT PRESENTATION STAR ORULLIAN – EXECUTIVE DIRECTOR GRANITE EDUCATION ASSOCIATION.
Honoring Choices at Ridgeview Medical Center Sue DeGolier July 19, 2012.
The Scientific Method involves a series of steps in which scientists answer questions and solve problems.
11 WAYS TO DECREASE DOOR TO NEEDLE TIME YOU CAN DO IT FASTER Jeff Nickel, MD FACEP ED Medical Director Parkview Regional Medical Center.
C OMPREHENSIVE & F OCUSED E VALUATIONS U SING P IVOT CEL5D+ Training Summer 2015 This session will: Give an overview of Comprehensive and Focused Evaluations.
Exceptional Children Program “Serving Today’s Students” Student Assistance Team.
CDR Implementation Trial
Guidance for VCA Deceased Donor Authorization (Resolution 7)
White Paper: Ethical Considerations of Imminent Death Donation
Case Study 24 y/o overdose with history of IVDA, found with needle in arm, & pronounced within 24 Hours of admission. Sharing Our Current Practices Hospital:
Protests and the Appeals Process
Copyright Cmassengale
UW Hospital and Clinics Organ Procurement Organization (OPO)
Eligibility and Informed Clinical Opinion
Other Testing Issues Chapter 7 Red book.
Overview.
1. Evaluation 2. Allocation 3. Organ Recovery Coordinator Name:
Culture of Donation Doug Miller Symposium 2013 Gundersen Lutheran
WHAT IS THE SCIENTIFIC METHOD?
Participant Retention
Acting on Every Donor’s Designated Decision: The Time is Now!
District Test Coordinators Training
How Do I Evaluate Workflow?
Standardized Huddles Process
More reminder calls, less no-shows, healthier systems, healthier patients! No-shows negatively affect the system by contributing to inefficiency and increased.
Brief In-Office Demonstrations Yield High Enrollment Rates
National Hospice and Palliative Care Organization’s Palliative Care Resource Series Creating Support for Your Community-Based Palliative Care Program.
National Immunization Conference 2005 March 22, 2005 ~ Washington D.C.
First-Person Authorization and DCDs
Presentation transcript:

Becoming Better Predictors of Death Region 5 Collaborative Chuck Zollinger Administrative Director, Organ Recovery

Snapshot DSA serves 3.6 million 9 ODCs (on the call schedule) 2-ODC model (sorta) One office (no satellite offices ) ~500 miles N to S 80:20 rule Withdraw in ICU 2-minute observation

WI tool is a good basis but is not enough ALL clinical indicators need to be examined before predicting whether pt will expire within 60, 90 or 120 o NIF -35=no way he’s going down, right? Respiratory assessment: o Usually prior to family involvement o CPAP trial (permission of MD) NIF, RR, TV, sats Often done over the phone due to imminent withdrawal call Variability in how NIF was obtained Missed opportunity lead to process change Lessons Learned

Ask MD to do 20-min trial, if tolerated – NIFs at start and end of CPAP trial Intent was to not give family false hope Wouldn’t offer DCD if unlikely to expire – Hospital and OPO staff uncomfortable w/duration Medical Director recommended we only do CPAP trials if family is on board with donation – Better transparency with staff and family – Reduced CPAP trial to 10 minutes – Allows us to have more control of how NIF is conducted Revised Process

Still finalizing tracking tool – Goal is to gather data on all evaluations We suspect having 2 NIFs will help guide decision – We’ve seen 10-point changes in short period of time— some stronger and some weaker We feel we’re able to give family more accurate information If we determine pt is unlikely to expire, we tell family he/she is not eligible If uncertain, we leave it up to the family Conclusions